Search for Clinical Trial Results

Sponsored By

Leukemia, Eosinophilic, Acute - 25 Studies Found

Status Study
Terminated Study Name: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2004-11-09
    Interventions:
    • Drug: idarubicin Given IV
Completed Study Name: Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2000-10-04
    Interventions:
    • Drug: cytarabine Given IV
Active, not recruiting Study Name: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2012-06-21
    Interventions:
    • Drug: Cytarabine Given IV
Terminated Study Name: Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2012-03-07
    Interventions:
    • Drug: eltrombopag olamine Give
Terminated Study Name: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2010-07-08
    Interventions:
    • Drug: entinostat Given orally

Completed Study Name: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2006-12-04
    Interventions:
    • Drug: alvocidib Given IV
Completed Study Name: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2006-09-29
    Interventions:
    • Drug: Bortezomib Given IV
Completed Study Name: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2006-07-13
    Interventions: Drug: lenalidomide Given orally Other Names:
Completed Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2005-09-20
    Interventions: Drug: Sorafenib Tosylate Given orally Other Names:
Completed Study Name: Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia Date: 2005-08-16
    Interventions:
    • Drug: sorafenib tosylate Given
Next >>>